Citation Impact

Citing Papers

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
2016
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Guidelines for the Primary Prevention of Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
2011
Transition from inflammation to proliferation: a critical step during wound healing
2016 Standout
Re-epithelialization and immune cell behaviour in an ex vivo human skin model
2020 Standout
Benefits and limitations of genome-wide association studies
2019
Lineage-Specific Changes in Biomarkers in Great Apes and Humans
2015 StandoutNobel
Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy
2011
Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines
2019
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
2013 Standout
Human Genetics Shape the Gut Microbiome
2014 Standout
Management of patients with hepatitis B who require immunosuppressive therapy
2013
Autoinflammatory Disease Reloaded: A Clinical Perspective
2010 Standout
Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials
2015
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
2015 Standout
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
The Role of the Sodium-Taurocholate Cotransporting Polypeptide (NTCP) and of the Bile Salt Export Pump (BSEP) in Physiology and Pathophysiology of Bile Formation
2010
Data Resource Profile: Clinical Practice Research Datalink (CPRD)
2015 Standout
Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics
2014 Standout
Poor Recognition of Risk Factors for Hepatitis B by Physicians Prescribing Immunosuppressive Therapy: A Call for Universal Rather than Risk-Based Screening
2015
Five Years of GWAS Discovery
2012 Standout
Guidelines for the Primary Prevention of Stroke
2010
Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy
2010
Consort 2010 statement: extension to cluster randomised trials
2012 Standout
Bayesian statistical methods for genetic association studies
2009
Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance
2014
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
Human genetic variation and its contribution to complex traits
2009
Genome-wide association meta-analysis for total serum bilirubin levels
2009
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
2019
Dermatomyositis, polymyositis and immune-mediated necrotising myopathies
2014
Why psychologists must change the way they analyze their data: The case of psi: Comment on Bem (2011).
2011 Standout
Systematic review of growth factors and cytokines for the management of oral mucositis in cancer patients and clinical practice guidelines
2020
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
2018 Standout
Sclerostin: how human mutations have helped reveal a new target for the treatment of osteoporosis
2013 StandoutNobel
Common SNPs explain a large proportion of the heritability for human height
2010 Standout
The Use of Genomic Information to Optimize Cancer Chemotherapy
2011
Coming of age: ten years of next-generation sequencing technologies
2016 Standout
Atherosclerosis
2019 Standout
Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality
2008
Pharmacogenomics: candidate gene identification, functional validation and mechanisms
2008
SLCO1B1 Genetic Variant Associated With Statin-Induced Myopathy: A Proof-of-Concept Study Using the Clinical Practice Research Datalink
2013
Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment
2016
Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center
2013
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Uncovering the roles of rare variants in common disease through whole-genome sequencing
2010
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Genome-wide association study for type 2 diabetes: clinical applications
2009
PharmGKB summary
2011
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial
2010
Bias in recruitment to cluster randomized trials: a review of recent publications
2011
Mining electronic health records: towards better research applications and clinical care
2012 Standout
The Emerging Role of Electronic Medical Records in Pharmacogenomics
2011
Resistance and intolerance to statins
2014
Sequencing technologies — the next generation
2009 Standout
When Are Statins Cost-Effective in Cardiovascular Prevention? A Systematic Review of Sponsorship Bias and Conclusions in Economic Evaluations of Statins
2013
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout
Combination therapy in dyslipidemia: Where are we now?
2014
Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy
2015
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Wound repair and regeneration: Mechanisms, signaling, and translation
2014 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Supramolecular biomaterials
2015 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Personalized Medicine: Progress and Promise
2011
Inflammatory Muscle Diseases
2015 Standout
Cytochrome P450 2C8 Pharmacogenetics: A Review of Clinical Studies
2009
Oxidative Stress, Prooxidants, and Antioxidants: The Interplay
2014 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Practical Recommendations for Pharmacogenomics-based Prescription: 2010 ESF–UB Conference on Pharmacogenetics and Pharmacogenomics
2010
Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction
2012
Models to Predict Hepatitis B Virus Infection Among Patients With Cancer Undergoing Systemic Anticancer Therapy: A Prospective Cohort Study
2018
Perspectives on low-density lipoprotein cholesterol goal achievement
2008
Guidelines for the Primary Prevention of Stroke
2014 Standout
Low Rates of Hepatitis B Virus Screening at the Onset of Chemotherapy
2012
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Organic Anion Transporting Polypeptide (OATP)1B1 and OATP1B3 as Important Regulators of the Pharmacokinetics of Substrate Drugs
2015
Review: Immune‐mediated necrotizing myopathies – a heterogeneous group of diseases with specific myopathological features
2012
Electronic health records for biological sample collection: feasibility study of statin‐induced myopathy using the Clinical Practice Research Datalink
2013
Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients
2009
Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial
2010
Approach to the Patient Who Is Intolerant of Statin Therapy
2010
Genomewide Association Studies and Assessment of the Risk of Disease
2010
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
2017 StandoutNobel
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
An Updated Definition of Stroke for the 21st Century
2013 Standout
Whole genome association studies in complex diseases: where do we stand?
2010
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
2012 Standout
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
2012 Standout
Inflammation and metabolism in tissue repair and regeneration
2017 StandoutScience
Macrophages, Inflammation, and Insulin Resistance
2010 Standout
Industry sponsorship and research outcome
2017 Standout
Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation
2009
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout

Works of Emma Link being referenced

SLCO1B1 Variants and Statin-Induced Myopathy — A Genomewide Study
2008
A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia
2014
Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study
2012
Current Hepatitis B Screening Practices and Clinical Experience of Reactivation in Patients Undergoing Chemotherapy for Solid Tumors: A Nationwide Survey of Medical Oncologists
2011
Rankless by CCL
2026